The Effectiveness of Warfarin Dosing from a Nomogram Compared with House Staff Dosing

Journal of Arthroplasty

Volumn 22, Issue 2, 2007, Pages 213-218

  Asnis, Peter D ^a   J Gardner, Michael ^a   Ranawat, Anil ^a   Leitzes, Anne H ^a   Peterson, Margaret G E ^a   Bass, Anne R ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

anticoagulation; arthroplasty; nomogram; orthopedic; thromboembolism; warfarin

Indexed keywords

WARFARIN;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HIP ARTHROPLASTY; HOSPITALIZATION; HUMAN; KNEE ARTHROPLASTY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; VENOUS THROMBOEMBOLISM;

AGED; ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; INTERNSHIP AND RESIDENCY; MALE; POSTOPERATIVE COMPLICATIONS; STATISTICS, NONPARAMETRIC; VENOUS THROMBOSIS; WARFARIN;

EID: 33846486754     PISSN: 08835403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arth.2006.03.006     Document Type: Article

References (14)

1. Geerts W.H., Pineo G.F., Heit J.A., et al. Prevention of venous thromboembolism. Chest 126 (2004) 338S
2. Westrich G.H., Haas S.B., Mosca P., et al. Meta-analysis of thromboembolic prophylaxis after total knee arthroplasty. J Bone Joint Surg Br 82 (2000) 795
3. Colwell C.W., Collins D.K., Paulson R., et al. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge. J Bone Joint Surg Am 81 (1999) 932
4. Robinson K.S., Anderson D.R., Gross M., et al. Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty. Ann Intern Med 127 (1997) 439
5. Anderson Jr. F.A., Hirsh J., White K., et al. Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001: findings from the Hip and Knee Registry. Chest 124 (2003) 349S
6. Hirsh J., Fuster V., Ansell J., et al. American Heart Association/American College of Cardiology Foundation Guide to warfarin therapy. Circulation 107 (2003) 1692
7. Rieder M.J., Reiner A.P., Gage B.F., et al. Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. N Engl J Med 352 (2005) 2285
8. Linkins L., Choi P.T., and Douketis J.D. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism. Ann Intern Med 139 (2003) 893
9. Poller L., Shiach C.R., MacCallum P.K., et al. Multicentre randomised study of computerised anticoagulant dosage. Lancet 352 (1998) 1505
10. Ageno W., Johnson J., Nowacki B., et al. A computer generated induction system for hospitalized patients starting on oral anticoagulant therapy. Thromb Haemost 83 (2000) 849
11. Anderson D.R., Wilson S.J., Blundell J., et al. Comparison of a nomogram and physician-adjusted dosage of warfarin for prophylaxis against deep-vein thrombosis after arthroplasty. J Bone Joint Surg Am 84 (2002) 1992
12. Kovacs M.J., Rodger M., Anderson D.R., et al. Comparison of 10-mg and 5-mg warfarin initiation nomograms together with low-molecular-weight heparin for outpatient treatment of acute venous thromboembolism. A randomized, double-blind, controlled trial. Ann Intern Med 138 (2003) 714
13. Francis C.W., Davidson B.L., Berkowitz S.D., et al. Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement. N Engl J Med 349 (2003) 1703
14. Merli G.J. Duration of deep vein thrombosis and pulmonary embolism prophylaxis after joint arthroplasty. Med Clin North Am 85 (2001) 1101